BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 16207874)

  • 1. CHIP suppresses polyglutamine aggregation and toxicity in vitro and in vivo.
    Miller VM; Nelson RF; Gouvion CM; Williams A; Rodriguez-Lebron E; Harper SQ; Davidson BL; Rebagliati MR; Paulson HL
    J Neurosci; 2005 Oct; 25(40):9152-61. PubMed ID: 16207874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E6-AP promotes misfolded polyglutamine proteins for proteasomal degradation and suppresses polyglutamine protein aggregation and toxicity.
    Mishra A; Dikshit P; Purkayastha S; Sharma J; Nukina N; Jana NR
    J Biol Chem; 2008 Mar; 283(12):7648-56. PubMed ID: 18201976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivo.
    Zhang X; Smith DL; Meriin AB; Engemann S; Russel DE; Roark M; Washington SL; Maxwell MM; Marsh JL; Thompson LM; Wanker EE; Young AB; Housman DE; Bates GP; Sherman MY; Kazantsev AG
    Proc Natl Acad Sci U S A; 2005 Jan; 102(3):892-7. PubMed ID: 15642944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: their role in suppression of aggregation and cellular toxicity.
    Jana NR; Tanaka M; Wang Gh; Nukina N
    Hum Mol Genet; 2000 Aug; 9(13):2009-18. PubMed ID: 10942430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Praja1 ubiquitin ligase facilitates degradation of polyglutamine proteins and suppresses polyglutamine-mediated toxicity.
    Ghosh B; Karmakar S; Prasad M; Mandal AK
    Mol Biol Cell; 2021 Aug; 32(17):1579-1593. PubMed ID: 34161122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of ubiquitin conjugates in a polyglutamine disease model occurs without global ubiquitin/proteasome system impairment.
    Maynard CJ; Böttcher C; Ortega Z; Smith R; Florea BI; Díaz-Hernández M; Brundin P; Overkleeft HS; Li JY; Lucas JJ; Dantuma NP
    Proc Natl Acad Sci U S A; 2009 Aug; 106(33):13986-91. PubMed ID: 19666572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential HspBP1 expression accounts for the greater vulnerability of neurons than astrocytes to misfolded proteins.
    Zhao T; Hong Y; Yin P; Li S; Li XJ
    Proc Natl Acad Sci U S A; 2017 Sep; 114(37):E7803-E7811. PubMed ID: 28847953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin inhibits polyglutamine aggregation independently of autophagy by reducing protein synthesis.
    King MA; Hands S; Hafiz F; Mizushima N; Tolkovsky AM; Wyttenbach A
    Mol Pharmacol; 2008 Apr; 73(4):1052-63. PubMed ID: 18199701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential activities of the ubiquitin-proteasome system in neurons versus glia may account for the preferential accumulation of misfolded proteins in neurons.
    Tydlacka S; Wang CE; Wang X; Li S; Li XJ
    J Neurosci; 2008 Dec; 28(49):13285-95. PubMed ID: 19052220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking acid-sensing ion channel 1 alleviates Huntington's disease pathology via an ubiquitin-proteasome system-dependent mechanism.
    Wong HK; Bauer PO; Kurosawa M; Goswami A; Washizu C; Machida Y; Tosaki A; Yamada M; Knöpfel T; Nakamura T; Nukina N
    Hum Mol Genet; 2008 Oct; 17(20):3223-35. PubMed ID: 18658163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of anti-prion compounds as efficient inhibitors of polyglutamine protein aggregation in a zebrafish model.
    Schiffer NW; Broadley SA; Hirschberger T; Tavan P; Kretzschmar HA; Giese A; Haass C; Hartl FU; Schmid B
    J Biol Chem; 2007 Mar; 282(12):9195-203. PubMed ID: 17170113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyglutamine tracts regulate beclin 1-dependent autophagy.
    Ashkenazi A; Bento CF; Ricketts T; Vicinanza M; Siddiqi F; Pavel M; Squitieri F; Hardenberg MC; Imarisio S; Menzies FM; Rubinsztein DC
    Nature; 2017 May; 545(7652):108-111. PubMed ID: 28445460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of polyglutamine aggregation in R6/2 HD brain slices-complex dose-response profiles.
    Smith DL; Portier R; Woodman B; Hockly E; Mahal A; Klunk WE; Li XJ; Wanker E; Murray KD; Bates GP
    Neurobiol Dis; 2001 Dec; 8(6):1017-26. PubMed ID: 11741397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hsp40 gene therapy exerts therapeutic effects on polyglutamine disease mice via a non-cell autonomous mechanism.
    Popiel HA; Takeuchi T; Fujita H; Yamamoto K; Ito C; Yamane H; Muramatsu S; Toda T; Wada K; Nagai Y
    PLoS One; 2012; 7(11):e51069. PubMed ID: 23226463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic recruitment of active proteasomes into polyglutamine initiated inclusion bodies.
    Schipper-Krom S; Juenemann K; Jansen AH; Wiemhoefer A; van den Nieuwendijk R; Smith DL; Hink MA; Bates GP; Overkleeft H; Ovaa H; Reits E
    FEBS Lett; 2014 Jan; 588(1):151-9. PubMed ID: 24291262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of mutant Huntingtin aggregate formation by Cdk5/p35 through the effect on microtubule stability.
    Kaminosono S; Saito T; Oyama F; Ohshima T; Asada A; Nagai Y; Nukina N; Hisanaga S
    J Neurosci; 2008 Aug; 28(35):8747-55. PubMed ID: 18753376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical ubiquitination by E3 ligase WWP1 inhibits the proteasome-mediated degradation of mutant huntingtin.
    Lin L; Jin Z; Tan H; Xu Q; Peng T; Li H
    Brain Res; 2016 Jul; 1643():103-12. PubMed ID: 27107943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herp Promotes Degradation of Mutant Huntingtin: Involvement of the Proteasome and Molecular Chaperones.
    Luo H; Cao L; Liang X; Du A; Peng T; Li H
    Mol Neurobiol; 2018 Oct; 55(10):7652-7668. PubMed ID: 29430620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function.
    Tsai YC; Fishman PS; Thakor NV; Oyler GA
    J Biol Chem; 2003 Jun; 278(24):22044-55. PubMed ID: 12676955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mechanism of Hsp70 chaperone-mediated prevention of polyglutamine aggregates in a cellular model of huntington disease.
    Guzhova IV; Lazarev VF; Kaznacheeva AV; Ippolitova MV; Muronetz VI; Kinev AV; Margulis BA
    Hum Mol Genet; 2011 Oct; 20(20):3953-63. PubMed ID: 21775503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.